首页/数据集/GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial

GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial

ChEBI2009-07-09 更新2026-07-21 收录

乳腺癌内分泌治疗

生物标志物预测

数据链接：

https://www.ebi.ac.uk/biostudies/ArrayExpress/studies/E-GEOD-16391 数据链接链接失效反馈

官方服务：

资源简介：

GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial

应用场景：

创建时间：

2009-07-09

乳腺癌内分泌治疗

激素剂量效应

An incomplete understanding of dose-dependent progesterone receptor (PR) biology has led to the suboptimal exploitation of PR as a therapeutic target. While hormone replacement therapies (HRT) contain

NIAID Data Ecosystem90

Multiplex predictors of imminent RA diagnosis.

关节炎早期诊断

生物标志物预测

Multiplex predictors of imminent RA diagnosis.

NIAID Data Ecosystem60

Risk of ESRD and All Cause Mortality in Type 2 Diabetes According to Circulating Levels of FGF-23 and TNFR1

糖尿病预后

生物标志物预测

Introduction Recent studies demonstrated that circulating fibroblast growth factor (FGF)-23 was associated with risk of end stage renal disease (ESRD) and mortality. This study aims to examine whether

NIAID Data Ecosystem40

SET ER/PR - A robust 18-gene Predictor for Sensitivity to Endocrine Therapy for Metastatic Breast Cancer. SET ER/PR - A robust 18-gene Predictor for Sensitivity to Endocrine Therapy for Metastatic Breast Cancer

乳腺癌内分泌治疗

肿瘤生物标志物

There is clinical need to predict sensitivity of metastatic hormone receptor-positive and HER2-negative (HR+/HER2-) breast cancer to endocrine therapy, and targeted RNA sequencing (RNAseq) offers diag

NIAID Data Ecosystem90

Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer

生物标志物预测

结直肠癌靶向治疗

This study evaluates the relationship of biomarker expression and efficacy of bevacizumab plus chemotherapy in patients with unresectable/metastatic colorectal cancer. Before the treatment, the invest

NIAID Data Ecosystem60

GGI: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1-98 trial

资源简介：

相关数据集